Tumor marker

Open Access
Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive Esophagectomy
RIKUYA TORIGOE, TARO OSHIKIRI, HIRONOBU GOTO, YASUHUMI KOTERAZAWA, RYUICHIRO SAWADA, TARO IKEDA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI

Anticancer Research December 2024, 44 (12) 5485-5493; DOI: https://doi.org/10.21873/anticanres.17374
You have access
Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer
MAKOTO NAKAO, RYOSUKE KINOSHITA, MAMIKO KURIYAMA, HIROKO KIYOTOSHI, MASAHIRO SUGIHARA, NORIHISA TAKEDA, KAZUHIRO OHTAKARA and HIDEKI MURAMATSU

Anticancer Research February 2024, 44 (2) 845-851; DOI: https://doi.org/10.21873/anticanres.16877
Open Access
Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis
NAEMI GLASER, ANNE PETZOLD, ANJA WESSELY, MATTHIAS D. KAUFMANN, ELIAS A.T. KOCH, HARALD KNORR, CAROLINE VOSKENS, MARKUS V. HEPPT, CAROLA BERKING and MICHAEL ERDMANN

Anticancer Research October 2023, 43 (10) 4525-4532; DOI: https://doi.org/10.21873/anticanres.16646
You have access
Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer
HIDETAKA KAWAMURA, MICHITAKA HONDA, YOSHINAO TAKANO, SHUNJI KINUTA, TAKAHIRO KAMIGA, SHIGEHIRA SAJI and KOJI KONO

Anticancer Research August 2022, 42 (8) 3921-3928; DOI: https://doi.org/10.21873/anticanres.15886
You have access
Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors
ARTURAS DOBILAS, CHARLOTTE THALIN, HAKAN WALLEN and CHRISTER BORGFELDT

Anticancer Research February 2022, 42 (2) 965-971; DOI: https://doi.org/10.21873/anticanres.15556
You have access
Clinical Impact of CYFRA 21-1 a Marker for Treatment Failure in Patients With Oropharyngeal Cancer Treated by Radio(chemo)therapy
STEFAN A. RUDHART, PHILIPP LANGEN, KRUTHIKA THANGAVELU, FRANCESCA GEHRT, PETAR STANKOVIC, THOMAS WILHELM, BORIS A. STUCK and STEPHAN HOCH

Anticancer Research January 2022, 42 (1) 137-146; DOI: https://doi.org/10.21873/anticanres.15467
You have access
The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung Tumors
JOSEF VODICKA, MARTIN SKALA, JAKUB SEBEK, VLADISLAV TRESKA, JAKUB FICHTL, KRISTYNA PROCHAZKOVA, BOHUSLAVA VANKOVA, MARTIN SVATON, LADISLAV PECEN, ONDREJ TOPOLCAN, MONIKA BLUDOVSKA and RADEK KUCERA

Anticancer Research October 2021, 41 (10) 5117-5122; DOI: https://doi.org/10.21873/anticanres.15328
You have access
Prognostic Impact of a Novel Tumor Marker and Inflammation Index for Patients With Non-small-cell Lung Cancer
MASAKI TOMITA, RYO MAEDA, TAKANORI AYABE and KUNIHIDE NAKAMURA

Anticancer Research July 2020, 40 (7) 4023-4027; DOI: https://doi.org/10.21873/anticanres.14397
You have access
Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients
EMILIA DĄBROWSKA, ANDRZEJ PRZYLIPIAK, MONIKA ZAJKOWSKA, BARBARA M. PISKOR, IWONA SIDORKIEWICZ, MACIEJ SZMITKOWSKI and SLAWOMIR LAWICKI

Anticancer Research June 2020, 40 (6) 3221-3229; DOI: https://doi.org/10.21873/anticanres.14303
You have access
Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver Tumors
SUSANNE FEDER, ARNE KANDULSKI, DORIS SCHACHERER, THOMAS S. WEISS and CHRISTA BUECHLER

Anticancer Research January 2020, 40 (1) 143-151; DOI: https://doi.org/10.21873/anticanres.13935

Main menu

User menu

Search

Tumor marker

Pages